Renal tubular damage in rasburicase: risks of alkalinisation.
van den Berg
H
H
Reintsema
A M
AM
D000468:Alkalies / Q000378:metabolism* / Q000652:urine; D002051:Burkitt Lymphoma / Q000150:complications / Q000628:therapy; D002130:Calcium Phosphates / Q000378:metabolism; D002648:Child; D003401:Creatine / Q000378:metabolism; D003956:Dialysis; D006801:Humans; D006863:Hydrogen-Ion Concentration; D007684:Kidney Tubules / Q000187:drug effects* / Q000473:pathology; D008297:Male; D012307:Risk Factors; D015275:Tumor Lysis Syndrome / Q000209:etiology / Q000503:physiopathology*; D014503:Urate Oxidase / Q000009:adverse effects / Q000494:pharmacology* / Q000627:therapeutic use; D014527:Uric Acid / Q000097:blood / Q000378:metabolism*; D014882:Water-Electrolyte Balance
D000468:Alkalies; D002130:Calcium Phosphates; C469709:rasburicase; D014527:Uric Acid; D014503:Urate Oxidase; D003401:Creatine